Watch STAA. Know when insiders buy.
One email the day a filing lands. Free.
STAA
STAAR SURGICAL CO
20.51
+1.43 +7.49%
USD · close Sep 25
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
57
WATCH · shorts 57
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1BP/E 256.4DIV YIELD —FCF YIELD -0.66%REV TTM $339.6M +51.3%NET INCOME $3.8MNET CASH —52W 16.10 – 33.34SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2027 · Jul 3 | $93.5M | +111.0% | 74.5% | $10.1M | $8.1M | — | 0.16 | $19.7M | $494K | $19.2M | Aug 12 |
| Q1 2027 · Apr 3 | $93.5M | +119.6% | 73.6% | $8M | $5.2M | — | 0.10 | −$21.7M | $443K | −$22.1M | May 13 |
| Q4 2026 · Jan 2derived | $57.8M | +18.1% | 75.7% | −$22.8M | −$18.3M | — | -0.36 | −$3.9M | $1.7M | −$5.6M | Mar 3 |
| Q3 2026 · Sep 26 | $94.7M | +6.9% | 82.2% | $18.5M | $8.9M | −11.0% | 0.18 | $2.7M | $883K | $1.8M | Nov 5 |
| Q2 2026 · Jun 27 | $44.3M | −55.2% | 74.0% | −$30M | −$16.8M | −327.8% | -0.34 | −$27.2M | $1.8M | −$29M | Aug 12 |
| Q1 2026 · Mar 28 | $42.6M | −44.9% | 65.8% | −$57.4M | −$54.2M | — | -1.10 | −$5.7M | $1.5M | −$7.2M | May 13 |
| Q4 2025 · Dec 27derived | $49M | −35.8% | 64.7% | −$27.9M | −$34.2M | −541.3% | -0.69 | $642K | $5.7M | −$5.1M | Mar 3 |
| Q3 2025 · Sep 27 | $88.6M | +10.3% | 77.3% | $5.7M | $10M | +107.2% | 0.20 | $3.8M | $6.2M | −$2.4M | Nov 5 |
| Q2 2025 · Jun 28 | $99M | — | 79.2% | $11.9M | $7.4M | — | 0.15 | −$10.4M | $6.2M | −$16.6M | Aug 6 |
| Q1 2025 · Mar 29 | $77.4M | — | 78.9% | −$2.3M | −$3.3M | — | -0.07 | $21.7M | $5.2M | $16.5M | May 7 |
| Q4 2024 · Dec 29derived | $76.3M | — | 79.6% | $10.4M | $7.8M | — | 0.16 | $32M | $3.1M | $28.9M | Mar 3 |
| Q3 2024 · Sep 29 | $80.3M | — | 79.2% | $6.3M | $4.8M | — | 0.10 | −$6M | $9.2M | −$15.2M | Oct 30 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Jan 2 | $239.4M | 76.2% | −$91.7M | −$80.4M | -33.6% | -1.62 | −$34.2M | $5.8M | −$40M | $6.5M | — |
| FY2025 · to Dec 27 | $313.9M | 76.3% | −$12.6M | −$20.2M | -6.4% | -0.41 | $15.7M | $23.4M | −$7.7M | — | — |
| FY2024 · to Dec 29 | $322.4M | 78.4% | $28.1M | $21.3M | 6.6% | 0.43 | $14.6M | $18.2M | −$3.6M | — | — |
| FY2023 · to Dec 30 | $239.4M | 93.3% | $43.8M | $39.7M | 16.6% | 0.80 | $35.7M | $18.1M | $17.6M | — | — |
| FY2022 · to Dec 31 | $230.5M | 77.5% | $33.3M | $27.5M | 11.9% | 0.56 | $44M | $13.6M | $30.3M | — | — |
| FY2022 · to Dec 30 | — | — | — | $27.5M | — | 0.56 | — | — | — | — | — |
Every number comes from STAAR SURGICAL CO's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.